Company / Current Assets
Dynavax Technologies Corp. Current Assets History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$848.9M
FY2024
5-year range
$290.0M / $972.5M
FY2020-FY2024
Trend
-1.2%
vs FY2023
Sector context
#66 of 215
Health Care
What the data says
At $849M, Dynavax Technologies Corp.'s current assets ranks #66 of 215 in the Health Care sector. Current Assets has declined for 3 consecutive years, from $973M in FY2021 to $849M in FY2024.
Based on SEC 10-K filings.
$849M in FY2024 with a 5-year CAGR of +32.4%.
Declined from $917M to $849M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -4.4%
- 5-Year CAGR
- +32.4%
- 10-Year CAGR
- -
Sector benchmark
#66 of 215 in Health CareTop 31% of 215This company $848.9M Sector average $2.5B
▼
-66.5% below sector average
Key checks
Key Insights
- Dynavax Technologies Corp.'s current assets has declined for 3 consecutive years.
- 5-year CAGR of +32.4%, indicating consistent growth.
- In FY2024, current assets decreased 1.2% year-over-year.
- Ranks #66 out of 215 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $848.9M | -1.2% |
| FY2023 | $859.1M | -6.3% |
| FY2022 | $917.0M | -5.7% |
| FY2021 | $972.5M | +235.3% |
| FY2020 | $290.0M | +39.0% |
| FY2019 | $208.7M | +19.7% |
| FY2018 | $174.4M | -11.9% |
| FY2017 | $198.0M | +121.0% |
| FY2016 | $89.6M | -55.2% |
| FY2015 | $199.9M | +56.9% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026